JP Morgan Chase’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11
Closed -$53 7323
2025
Q1
$53 Sell
11
-1
-8% -$5 ﹤0.01% 6978
2024
Q4
$62 Buy
+12
New +$78 ﹤0.01% 7089
2024
Q3
Sell
-12
Closed -$97 7518
2024
Q2
$97 Hold
12
﹤0.01% 6896
2024
Q1
$90 Buy
+12
New +$91 ﹤0.01% 6925
2023
Q1
Sell
-4,444
Closed -$52K 6934
2022
Q4
$52K Sell
4,444
-722
-14% -$7.99K ﹤0.01% 5608
2022
Q3
$58K Buy
+5,166
New +$68.9K ﹤0.01% 5495
2019
Q3
Sell
-164
Closed 5829
2019
Q2
$0 Hold
164
﹤0.01% 5854
2019
Q1
$1K Hold
164
﹤0.01% 5688
2018
Q4
$0 Sell
164
-821
-83% -$3.92K ﹤0.01% 5778
2018
Q3
$7K Buy
985
+821
+501% +$7.22K ﹤0.01% 5533
2018
Q2
$2K Hold
164
﹤0.01% 5466
2018
Q1
$2K Sell
164
-520
-76% -$4.76K ﹤0.01% 5282
2017
Q4
$6K Sell
684
-635
-48% -$6.4K ﹤0.01% 5304
2017
Q3
$13K Sell
1,319
-7,566
-85% -$69.6K ﹤0.01% 4676
2017
Q2
$92K Sell
8,885
-7,745
-47% -$97.6K ﹤0.01% 4201
2017
Q1
$233K Sell
16,630
-7,554
-31% -$115K ﹤0.01% 4016
2016
Q4
$365K Sell
24,184
-9,152
-27% -$139K ﹤0.01% 3908
2016
Q3
$540K Buy
33,336
+6,244
+23% +$103K ﹤0.01% 3378
2016
Q2
$431K Sell
27,092
-19,994
-42% -$353K ﹤0.01% 3485
2016
Q1
$1.19M Buy
47,086
+47,038
+97,996% +$1.44M ﹤0.01% 2990
2015
Q4
$2K Sell
48
-1,878
-98% -$70.3K ﹤0.01% 4518
2015
Q3
$68K Sell
1,926
-17,816
-90% -$804K ﹤0.01% 3775
2015
Q2
$1.18M Buy
19,742
+140
+0.7% +$9.41K ﹤0.01% 3204
2015
Q1
$1.53M Sell
19,602
-2,102
-10% -$163K ﹤0.01% 3001
2014
Q4
$1.68M Buy
21,704
+17,077
+369% +$1.12M ﹤0.01% 3060
2014
Q3
$294K Sell
4,627
-21,916
-83% -$1.49M ﹤0.01% 3867
2014
Q2
$1.91M Sell
26,543
-1,027
-4% -$79.3K ﹤0.01% 2557
2014
Q1
$2.44M Sell
27,570
-5,083
-16% -$396K ﹤0.01% 2448
2013
Q4
$2.55M Sell
32,653
-14,768
-31% -$1.2M ﹤0.01% 2601
2013
Q3
$4.19M Buy
47,421
+11,237
+31% +$1.03M ﹤0.01% 2305
2013
Q2
$3.11M Buy
+36,184
New +$3M ﹤0.01% 2465

Other funds holding HHS

JP Morgan Chase's HHS Position: Q2 2025 in Review

JP Morgan Chase sold out of Harte-Hanks (HHS) in Q2 2025, closing a stake of 11 shares — an estimated $53 sold.

JP Morgan Chase first reported a position in HHS in Q2 2013 and held it in 31 quarters. The position peaked at $4.19M in Q3 2013. 23 funds tracked by Wall St. Rank hold HHS as of Q2 2025.

  • JP Morgan Chase reported no remaining Harte-Hanks position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 11 Harte-Hanks shares in Q2 2025, an estimated $53.
  • JP Morgan Chase first reported a position in Harte-Hanks in Q2 2013 and held it in 31 quarters.
  • JP Morgan Chase's Harte-Hanks position peaked at $4.19M in Q3 2013.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.